• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2020
  • Select Year
    1. 2025
    2. 2024
    3. 2023
    4. 2022
    5. 2021
    6. 2020
    7. 2019
    8. 2018
    9. 2017
    10. 2016
    11. 2015
    12. 2014
    13. 2013
    14. 2012
    15. 2011
    16. 2010
    17. 2009
    18. 2008
    19. 2007
  • 16.12.2020

    Announcements and Notices - [Major Transaction / Termination of Transaction] TERMINATION OF MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR

  • 02.12.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020

  • 27.11.2020

    Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2020

  • 24.11.2020

    Circulars - [Major Transaction] MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR

  • 16.11.2020

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 13.11.2020

    Announcements and Notices - [Profit Warning / Inside Information] PROFIT WARNING

  • 02.11.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October, 2020

  • 27.10.2020

    Announcements and Notices - [Major Transaction / Delay in Dispatch of Circular or other Document] DELAY IN DESPATCH OF CIRCULAR AND GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 14.41(A) OF THE LISTING RULES

  • 06.10.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020

  • 05.10.2020

    Announcements and Notices - [Major Transaction] MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR

  • 01.09.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020

  • 31.08.2020

    Announcements and Notices - [Amendment of Constitutional Documents] Memorandum of Association and Amended and Restated Articles of Association

  • 28.08.2020

    Announcements and Notices - [Results of AGM] POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 AUGUST 2020

  • 04.08.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020

  • 28.07.2020

    Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING

  • 28.07.2020

    Proxy Forms PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING (THE "AGM") OF TIANDA PHARMACEUTICALS LIMITED TO BE HELD ON FRIDAY, 28 AUGUST 2020 AT 10:30 A.M. (OR AT ANY ADJOURNMENT THEREOF)

  • 28.07.2020

    Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares / Share Option Scheme / Amendment of Constitutional Documents] PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES RE-ELECTION OF RETIRING DIRECTORS; PROPOSED ADOPTION OF NEW SHARE OPTION SCHEME; PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND NOTICE OF ANNUAL GENERAL MEETING

  • 23.07.2020

    Announcements and Notices - [Amendment of Constitutional Documents] PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

  • 21.07.2020

    Announcements and Notices - [Dividend or Distribution / Closure of Books or Change of Book Closure Period] Final Dividend For The Year Ended 31 March 2020 Closures Of Register Of Members

  • 02.07.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June, 2020

  • 24.06.2020

    Announcements and Notices - [Final Results / Dividend or Distribution] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2020

  • 12.06.2020

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 01.06.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May, 2020

  • 07.05.2020

    Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - AUSTRALIAN REGISTER OF THERAPEUTIC GOODS ENTRY APPROVAL FOR THE GROUP'S "ANTI-EPIDEMIC FORMULA 1" TCM GRANULES

  • 04.05.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April, 2020

  • 03.04.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March, 2020

  • 03.03.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February, 2020

  • 28.02.2020

    Announcements and Notices - [Continuing Connected Transaction] CONTINUING CONNECTED TRANSACTIONS: REVISION OF ANNUAL CAPS AND EXTENSION OF PURCHASING PACKAGE PRODUCTS AND DESIGNING SERVICES

  • 03.02.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January, 2020

  • 07.01.2020

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice